Accessing tyrosine kinase inhibitors (TKIs) for Chronic Myeloid Leukemia (CML) varies across Canadian provinces. Below is a step-by-step guide for patients in Alberta.
Alberta:
Consultation: Meet with your oncologist to evaluate TKI treatment options.
Prescription: Your doctor will prescribe the suitable TKI based on your condition.
Coverage: Alberta Health Services provides coverage for certain TKIs through the Outpatient Cancer Drug Benefit Program. Verify the inclusion of your prescribed TKI.
Application: If required, your healthcare provider will assist in the application process.
Approval: After approval, the medication can be obtained from specified pharmacies.
Drugs approved for treatment of CML at the Alberta Cancer Agency:
Scemblix (Ascinimib), Bosulif (Bosutinib), Sprycel (Dasatinib), Gleevec (Imatinib), Tasigna (Nilotinib), Iclusig (Ponatinib).
Accessing tyrosine kinase inhibitors (TKIs) for Chronic Myeloid Leukemia (CML) varies across Canadian provinces. Below is a step-by-step guide for patients in Alberta.
Alberta
Consultation: Meet with your oncologist to evaluate TKI treatment options.
Prescription: Your doctor will prescribe the suitable TKI based on your condition.
Coverage: Alberta Health Services provides coverage for certain TKIs through the Outpatient Cancer Drug Benefit Program. Verify the inclusion of your prescribed TKI.
Application: If required, your healthcare provider will assist in the application process.
Approval: After approval, the medication can be obtained from specified pharmacies.
Drugs approved for treatment of CML at the Alberta Cancer Agency:
Scemblix (Ascinimib), Bosulif (Bosutinib), Sprycel (Dasatinib), Gleevec (Imatinib), Tasigna (Nilotinib), Iclusig (Ponatinib).
